Boeminghaus F, von Spiess H
Urologe A. 1981 Jul;20(4):190-5.
Our experience with carcinoma in solitary kidney is presented. We prefer the enucleation of the tumor or the partial resection of the kidney in normothermic ischemia. Two patients underwent total nephrectomy and hemodialysis. 5 patients with carcinoma in a solitary kidney survived an average of 20 months (max. 6 years), 5 patients died on an average of 21 months (1 week - 5 1/2 years). 2 out of 5 patients with simultaneous bilateral kidney tumors died 1 and 33 months after the operation, the 3 others survived 2-44 months till now. Enucleation and partial resection as therapy for tumors in solitary kidney can be recommended. The results are good concerning survival and renal function. The histology of bilateral kidney-tumors (consecutive or simultaneous) shows the criteria of primary carcinoma.
本文介绍了我们对孤立肾中癌的治疗经验。我们更倾向于在常温缺血状态下对肿瘤进行剜除术或肾脏部分切除术。两名患者接受了全肾切除术并进行血液透析。5例孤立肾癌症患者平均存活20个月(最长6年),5例患者平均在21个月(1周 - 5年半)死亡。5例同时患有双侧肾肿瘤的患者中,2例在术后1个月和33个月死亡,另外3例至今存活2 - 44个月。可以推荐采用剜除术和部分切除术治疗孤立肾肿瘤。在生存和肾功能方面,结果良好。双侧肾肿瘤(连续或同时发生)的组织学表现符合原发性癌的标准。